EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The multifaceted role of a-to-i rna editing in tumorigenesis: from coding to noncoding RNAs

Hussein Sabit iD, Rawan M Abdelazeem, Aysha Ghazy, Nouran Mohamed, Shaimaa Abdel-Ghany

Cancer Cell International · 17.11.2026 · 26 (1)

DOI: 10.1186/s12935-026-04475-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Cell International, online erschienen am 17.11.2026. Verfasst von Hussein Sabit und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, College of Biotechnology, Misr University for Science and Technology, P. O. Box 77, Giza, Egypt. Hussein.sabit@m…. Die Arbeit nennt 313 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Misr University for Science & Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA editing, a post-transcriptional process altering RNA sequences, is crucial in cancer progression. Adenosine-to-inosine (A-to-I) editing, mediated by ADAR enzymes, and cytosine-to-uridine (C-to-U) editing, by APOBEC proteins, diversify the transcriptome and proteome. Dysregulation of RNA editing significantly impacts gene expression, promoting tumorigenesis through alterations in amino acid sequences, transcript stability, and miRNA targeting. Conflicting research highlights the complexity of RNA editing’s role in cancer. While hyper-editing often correlates with editase overexpression and aggressive phenotypes, hypo-editing links to lower expression. Specific RNA editing events, rather than overall levels, offer more precise insights. ADAR1 primarily promotes oncogenesis, while ADAR2 generally acts as a tumor suppressor. ADAR3’s role remains unclear. RNA editing also influences noncoding RNAs, including miRNAs and lncRNAs, affecting their function and stability. A-to-I editing regulates miRNA biogenesis and mRNA-miRNA interactions, altering target gene selection and processing. LncRNAs, susceptible to A-to-I editing, undergo modifications that disrupt crucial molecular interactions, impacting their roles as miRNA sponges and regulators of gene expression. CircRNAs, through ADAR-mediated regulation, contribute to the complexity of RNA editing’s influence on cancer. This review underscores RNA editing’s multifaceted role in cancer, impacting key signaling pathways and immune surveillance. Understanding these mechanisms is vital for developing targeted therapies and improving cancer outcomes.

Schlagwörter

Stichwörter der Autor:innen

ADAR enzymesCancer progressionNoncoding RNAsRNA editingmiRNA regulation

Autor:innen und Institutionen

  • Department of Medical Biotechnology, College of Biotechnology, Misr University for Science and Technology, P. O. Box 77, Giza, Egypt. Hussein.sabit@must.edu.eg.
  • Department of Medical Biotechnology, College of Biotechnology, Misr University for Science and Technology, P. O. Box 77, Giza, Egypt.
  • Department of Agriculture Biotechnology, College of Biotechnology, Misr University for Science and Technology, P. O. Box 77, Giza, Egypt.
  • Department of Environmental Biotechnology, College of Biotechnology, Misr University for Science and Technology, P. O. Box 77, Giza, Egypt.

ORCID-Profile: Hussein Sabit

Förderung

  • Misr University for Science & Technology

Zitieren

APA

Sabit, H., Abdelazeem, R. M., Ghazy, A., Mohamed, N., & Abdel-Ghany, S. (2026). The multifaceted role of a-to-i rna editing in tumorigenesis: from coding to noncoding RNAs. Cancer Cell International, 26(1). https://doi.org/10.1186/s12935-026-04475-0

Vancouver

Sabit H, Abdelazeem RM, Ghazy A, Mohamed N, Abdel-Ghany S. The multifaceted role of a-to-i rna editing in tumorigenesis: from coding to noncoding RNAs. Cancer Cell International. 2026;26(1). doi:10.1186/s12935-026-04475-0

BibTeX
@article{Sabit2026,
  author = {Sabit, Hussein and Abdelazeem, Rawan M and Ghazy, Aysha and Mohamed, Nouran and Abdel-Ghany, Shaimaa},
  title = {The multifaceted role of a-to-i rna editing in tumorigenesis: from coding to noncoding RNAs},
  journal = {Cancer Cell International},
  year = {2026},
  volume = {26},
  number = {1},
  doi = {10.1186/s12935-026-04475-0}
}
Kostenlos starten →